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The peptide chains of immunoglobulins show extensive variability, since all 
the  proteins  analyzed so  far have been shown  to  have  a  unique  amino  acid 
sequence (1). Several genetic theories have been put forward to account for this 
variability (2). These theories can be subdivided into two major groups: germ 
line theories which postulate the existence of as many genes in the germ line 
as  there  are  immunoglobulin  chains,  and  somatic  variation  theories  which 
postulate  that  some  specific  mechanism(s)  exists  to  generate  variability  in 
amino acid sequences coded by a few genes. 
It seems essential to possess an estimate of the number of different sequences 
which are found in a given species in order to provide the correct explanation for 
the variability of immunoglobulins. We have attempted to reach this estimate 
by analyzing  a  large number  of human  light  chains  by peptide mapping.  A 
convenient  source  of  human  light  chains  is  found  in  Bence  Jones  proteins, 
secreted by patients with multiple myeloma. These proteins can be easily puri- 
fied and compared by peptide mapping (3). This method of analysis allows us to 
establish whether two proteins are different. However, to establish whether two 
proteins are identical, it is necessary to determine their amino acid sequence. 
It has been questioned whether the light chains obtained from Bence Jones 
proteins  are  representative  of the  population  of light  chains  present in  anti- 
bodies.  The  recent  demonstration  that  many  human  and  murine  myeloma 
immunoglobulins possess antibody activity (4-7) suggests that the light chains 
present in these proteins, and thus the corresponding Bence Jones proteins, can 
be  considered  constituents  of  antibodies. 
No two identical proteins have been found in the sample of 102 Bence Jones 
proteins  analyzed.  The  probability  of  not  finding  two  identical  proteins  in 
sampling populations of different sizes has been calculated  and has led  to an 
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estimate of  the  minimal number of  sequences of  light chains which  exist  in 
man. This number is rather large, at least a few thousand. 
Malerials and Melhods 
Protein Specimens.--The Bence Jones proteins studied were obtained from the sources pre- 
viously reported (3). In addition, proteins BJ 65 to BJ 70 were donated by Dr. B. Jirgensons, 
M.D.  Anderson Hospital and Tumor Institute, University of Texas, Houston, Tex.; proteins 
BJ 74 to BJ 79 were donated by Dr. M. Adinolfi, Wright-Fleming Institute of Microbiology, 
St. Mary's Hospital Medical School, London, England; proteins BJ 83 to BJ 85 by Dr. M. 
LaVia, Department of Pathology,  University of Colorado Medical Center,  Denver, Colo.; 
proteins BJ 86 to BJ 88 by Dr.  P. Heller, Department of Medicine, University of Illinois 
Medical School, Chicago, Ill.; proteins BJ 90 to BJ 96 by Dr. H. G. van Eijk, Laboratorium 
for Fysiologische Chemic der Rijkuniversiteit,  Utrecht,  Holland; protein  BJ 97  by Dr.  A. 
Sehon, Department  of Biochemistry, McGill University, Montreal, Canada; proteins BJ 103 
to BJ 111 and protein BJ 123 by Dr. R. L. Engle, Jr., Department of Medicine, Cornell Uni- 
versity Medical School, New York; proteins BJ 112 to BJ 122 by Dr. C. E. Buckley, Duke 
University, Durham, N. C.; proteins BJ 127 to BJ 131 by Dr. C. Milstein, Medical Research 
Council Unit of Molecular Biology, Cambridge, England; proteins BJ 125 and BJ 137 by Dr. 
A.  Carbonara,  Istituto di  Genetica  Medica, Universita  di Torino,  Torino,  Italy; protein 
BJ  142 by Dr. D. Ein, Immunology Branch, National Cancer Institute, National Institutes 
of Health, Bethesda, Md. All the other proteins were prepared in our laboratory from urines 
collected from patients of the Department  of Hematology, Ospedali Riuniti, Napoli; the Isti- 
tuto di Patologia Medica, Universita  di Napoli; and the Istituto dei Tumori,  Napoli. The 
proteins were purified as previously described (8). The proteins were aminoethylated and iso- 
lated  by gel filtration on Sephadex G-100 as previously indicated  (3). Chromatograms of 
several proteins have been shown previously (3); identical criteria were used in the present 
investigation for the isolation of the aminoethylated Bence Jones proteins; the fractions con- 
taining Bence Jones protein were combined and lyophilized. 
Analysis of Proteins.--The lyophilized proteins were digested with trypsin and analyzed 
by peptide mapping as previously described (8). Peptides were isolated from tryptic digests 
by a combination of gel filtration on Sephadex G-25 or Bio-Gel P-2 and column chromatog- 
raphy on Dowex-50, according to the procedures previously described (9). Alternatively,  the 
peptides were eluted from peptide maps run in high voltage ionophoresis at pH 4.7 (2 hr at 
5 kv)  and in ascending chromatography  as previously described  (10). The peptides were 
eluted with 0.1 ~ acetic acid and hydrolyzed in 6 ~ HC1 for 16 hr at ll0°C. The hydrolysates 
were analyzed in a Beckman 120 C amino acid analyzer. 
RESULTS 
Including the  proteins analyzed earlier (3),  102  Bence Jones proteins have 
now been studied. These proteins were purified by gel filtration on Sephadex 
G-100 after aminoethylation and were then analyzed by peptide mapping after 
tryptic digestion. The  gel filtration analysis separated  in many cases  Bence 
Jones  protein  "fragments"  corresponding to  the  variable part  of  the  Bence 
Jones proteins (11). 
The primary purpose of the present investigation was to determine the extent 
of variability in human Bence Jones proteins. For this reason,  a  simple ana- 
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time-consuming methods of analysis. Visual inspection of the peptide maps of 
two proteins allows one to establish whether the two proteins are different in 
amino acid sequence or not. If the two peptide maps are identical, no decision 
as to whether the amino acid sequences of the two proteins are identical can 
be taken, but at least isolation and amino acid analysis of the tryptic peptides is 
required for this purpose. 
In practice, at least four peptide maps of each protein analyzed were run. 
These peptide maps were stained with ninhydrin and then with the reagents 
specific for either tryptophan, tyrosine, arginine, or reduced sulfur and histidine 
(8). A composite map containing all the information obtained from the different 
peptide maps was then drawn; the reactions of specific amino acids were color- 
coded to facilitate comparison of peptide maps. Each composite peptide map 
was then compared with the peptide maps of all the other Bence Jones proteins 
previously analyzed to establish identity or nonidentity. 
Whenever peptide maps of two proteins looked similar, the tryptic digests 
were again analyzed by running the peptide maps side by side. The original 
method of Ingrain (12),  a modification of which has been used (13),  is particu- 
larly suited to compare proteins pairwise, since two peptide maps can be run 
simultaneously in electrophoresis and chromatography. 
102 Bence Jones proteins, 52 of K  type and 50 of L type, have been analyzed 
by peptide mapping in the present study. No two identical proteins have been 
observed by this method of analysis. This has confirmed previous observations 
(14-15)  that light chains of immunoglobulins show remarkable heterogeneity 
in the amino acid sequence of the variable region. 
Analysis  of K  Type Bence Jones  Proteins.--In  analyzing the Bence Jones 
proteins  by  peptide  mapping,  several  observations  were  made  which  con- 
tributed significantly to our knowledge of the variability of these proteins. The 
tryptic peptides of the invariable  C-terminal half were  compared in  all the 
pepfide maps. No variation of any of the peptides was observed beside that 
previously reported for peptide K9N (9). The presence of valine in this peptide 
corresponds to Inv(--2)  proteins, whereas leucine corresponds to Inv(2) pro- 
teins. 
Of the 52 K  type proteins studied, 6 showed the peptide K9N, which con- 
tains  leucine,  characteristic  of Inv(2)  proteins  (Table  I).  The  frequency of 
Inv(2) proteins observed (11.5 %) corresponds fairly well with that of the Inv(2) 
gene in European populations  (16  17), from which most of our samples were 
obtained. 
Six of the urinary K  type proteins studied separated into a Bence Jones pro- 
tein and a fragment when analyzed by gel filtration on Sephadex G-100 (Table 
I). The peptide maps of these fragments showed only the tryptic peptides of 
the variable N-terminal half, which were observed in the peptide maps of the 
corresponding proteins. TABLE  I 
Type K  Bence Jones Proleins 
Protein  Subtype  Inv (2)  Fragment  Observations 
3  II  --  -- 
4  I  +  -- 
5  I  -  -- 
6  III  --  -- 
9  ?  --  -- 
11  ?  --  -- 
14  I  --  -- 
15  III  --  -- 
16  II  --  -- 
19  I  --  4- 
21  II  --  -- 
26  I  --  - 
31  I  --  -- 
33  I  --  -- 
36  I  -  4- 
39  II  --  -- 
41  I  --  -- 
43  I  --  -- 
45  I  --  -- 
48  I  --  4- 
50  II  --  -- 
53  I  --  -- 
54  II  --  -- 
56  I  --  -- 
63  ?  --  -- 
66  I  --  -- 
68  I  --  -- 
73  I  --  -- 
86  I  4-  -- 
92  I  --  + 
94  I  +  + 
95  I  --  -- 
96  ? 
103  III  --  - 
104  III  --  -- 
106  ?  --  -- 
112  ?  --  -- 
114  I  +  -- 
115  I  --  -- 
116  I  --  -- 
118  ?  --  -- 
119  I  --  -- 
120  ? 
123  I  --  -- 
124  III  --  -- 
126  I  --  -- 
130  ?  4-  -- 
131  II  --  -- 
136  ?  --  -- 
137  ?  -  -- 
139  ?  -  + 
140  ?  4-  - 
1-18 and  19-23 analyzed* 
1-18 and  19-23 analyzed 
1-18 and  19-23 analyzed 
Only  19-23 present 
Only  19-23 present 
1-18 and  19-23 analyzed 
Only  19-23 present 
1-18 and  19-23 analyzed 
Only  19-23 present 
Only  19-23 present 
Only  1-18 present 
Only  1-18 present 
1-18 and  19-23 analyzed 
Only  1-18 present 
Only  1-18 present 
*  Numbers  refer  to  the  position  of  peptides  in  the  amino  acid  sequence  of  light  chains: 
i.e., peptide  1-18 contains  the  first  18 amino  acids from  the N-terminus. 
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One of the proteins from which  a  fragment was  isolated  (BJ 94)  was  an 
Inv(1,2) protein. This BJ 94 fragment was used in an attempt to localize the 
Inv(1) serological specificity. Bence Jones proteins are in general Inv(1,2)  or 
Inv(-1,-2),  but some myeloma immunoglobulins have been reported, which 
are Inv(1,-2)  (18-19).  It has thus been suggested that either the Inv(1) or 
the Inv(2) serological specificity may be localized in the variable part of the K 
type light chains and that it is in some way linked with the other Inv allele. 
However, the fragment isolated from the Bence Jones protein which was typed 
as Inv(1,2) failed to inhibit the Inv(1) and Inv(2) serological reactions  1. From 
these experiments, it was  co.ncluded that  the Inv serological specificities are 
probably not localized in the variable region. It cannot be excluded, however, 
that an Inv determinant is localized in an amino acid sequence which overlaps 
the variable and invariable region or that this determinant is expressed in the 
intact light chains only and not in a fragment. 
It has been possible (Table I) to assign most K  type Bence Jones proteins to 
each of the three subtypes described by Milstein  (20). These K  subtypes are 
defined by a  characteristic sequence of the first 23 residues. Aminoethylated 
proteins of subtype I show in peptide maps two tryptic peptides corresponding 
to the first 23 residues of the variable half. The first peptide of 18 amino acids, 
1-18,  contains methionine in the fourth position and  arginine as the COOH- 
terminal amino acid (20). This peptide has been identified on peptide maps of 
K type Bence Jones proteins; it is often divided characteristically into two spots 
because of the oxidation of part of a methionine residue to methionine sulfoxide 
(3).  The second  peptide,  19-23,  contains  five amino  acids  and  aminoethyl- 
cysteine is the COOH-terminal; this peptide also has been identified in peptide 
maps of Bence Jones proteins (3). Very little variability is observed in these two 
peptides and only few amino acid interchanges have been described (1). 
Proteins of subtype II have proline instead of arginine at position 18, besides 
having other interchanges,  and thus a  single peptide of 23  amino  acids with 
COOH-terminal  aminoethylcysteine is  present  in  the  tryptic digest  of these 
proteins; this peptide has not been identified in peptide maps run at pH 6.4 and 
it is  possible  that it precipitates with the insoluble  "core" material which  is 
formed at the end of the tryptic digestion (8). In peptide maps of proteins of 
this subtype, both peptides 1-18 and 19  23 observed in peptide maps of proteins 
of subtype I are absent. 
Proteins of subtype III have arginine at position 18, but no methionine at 
position 4; peptide i  16' can thus be easily distinguished from that of proteins of 
subtype I, since it does not give the reaction typical of reduced sulfur. Peptide 
19-23,  moreover, has  a  different sequence  (alanine  instead  of valine)  and  a 
different RI in chromatography from peptide 19-23 of proteins of subtype I. 
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By these criteria, most K  type proteins analyzed could be assigned to one of 
the subtypes described. Of 52 proteins analyzed, 27 were of subtype I, 7 of sub- 
type II and 5 of subtype III.  13 proteins were not assigned to any subtype, 
either because of incomplete information available or because of lack of any 
precise indications.  Most of these proteins do not show any of the peptides 
characteristic of subtype I  or III and were thought in some cases to belong to 
subtype  II. 
The relative frequency of proteins of the three subtypes was 69%, 18%, and 
13%  in the sample analyzed, compared to the frequency of 55%,  10%,  and 
35 %  calculated on a  smaller sample of proteins which have been partially or 
totally sequenced  (1).  We have no  explanation for the  inversion in  the  fre- 
quency of subtype II and III that we have observed, except for the fact that the 
calculations are based on small numbers and that our method of subtype assign- 
ment is not as reliable as sequencing. It seems, however, clear that subtype I is 
by far the most frequent. The tryptic peptides 1-18 and 19-23 of six proteins 
of subtype I  have been isolated and  analyzed.  Peptide 1-18 has  amino  acid 
composition identical to that of protein Ag (21) in three proteins (BJ 4, 26, and 
48), whereas it shows a methionine-isoleucine interchange in BJ  19;  a valine- 
to-leucine and serine-to-alanine interchange in BJ 68; and a  leucine-to-valine 
interchange in BJ  116.  Sequence studies on these and  other proteins will  be 
reported in detail elsewhere3 Peptide 19-23 of these six proteins has amino acid 
composition identical to that of protein Ag (21). It can thus be concluded that 
the results of the analysis of these proteins confirm the assignment to subtype I, 
based on peptide map analysis. 
In five proteins that have been assigned to subtype I  (BJ 36, 43, 56, 73, and 
95) peptide 1-18 could not be identified on the peptide maps, whereas peptide 
19-23 was clearly identified in the expected position. These proteins have thus 
been  tentatively  assigned  to  subtype  I,  although  no  explanation  has  been 
provided for the absence of peptide 1  18. Amino acid interchanges present in 
this peptide may cause a change in  its  ionophoretic or  chromatographic be- 
havior which prevents its identification. 
Similarly, in four other proteins,  only peptide  1-18 was  clearly identified, 
whereas peptide 19-23 was not (Table I). 
Peptide Map Variability and Amino Acid Interchanges.--We have previously 
attempted to establish the minimal number of amino acid interchanges between 
Bence Jones proteins by comparing their peptide maps (3). We concluded that 
there are an average of nine peptide differences between K  type proteins and 
that the minimal number of different peptides observed is six (3). At least one 
amino acid interchange may correspond to each peptide difference. In examining 
a  larger sample of Bence Jones proteins, we have noticed that some proteins 
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give very similar peptide maps. Proteins BJ 39  and BJ 50  show for instance 
several peptides  in identical position  in their peptide maps  (3).  Even  more 
striking, however, was the similarity observed for proteins BJ 68 and BJ 116 
FIO.  1.  Peptide maps of protein BJ 68 (A) and BJ 116  (B) 
(Fig. 1). Most of the distinctive peptides of these two proteins occupy identical 
positions in peptide maps, although some minor differences are clearly visible. 
It was thus decided to isolate and analyze the tryptic peptides of proteins 
BJ 68 and BJ 116 to evaluate how similar these two proteins are in amino acid 
sequence. The tryptic digests of these proteins were separated by high voltage 
ionophoresis at pH 4.7  followed by chromatography (10).  The  peptides  were 408  IMMUNOGLOBULIN STRUCTURE.  III 
eluted,  hydrolyzed,  and  analyzed. A  summary  of  the  amino  acid  analysis of 
distinctive peptides is reported in Table II. 
The  analysis of the tryptic peptides showed  that  these proteins differ in at 
least six positions. The  differences are caused  by  amino  acid interchanges  in 
peptides which  have  been  localized in  the  amino  acid sequence  by homology 
with the sequence of protein Ag (21) and by the presence or absence of peptides 
TABLE  II 
Analysis of the Tryptic Pe~tides of Proteins BJ 68 and BJ 116 
Peptide  BJ 68  Position  in  BJ 116 
sequence* 
2  Asp2  Ile Met Ser4 Glu2 Thr Pro  1-18  Asp2 Ile Met Set5 Glu2 Pro Ala 
Leu~ Ala2 Gly Arg  Val.s Gly Arg 
4  Asp Ser Glu2 Pro2 Ile Leu Phe  ?  Asp Ser Glu2 Pro2 Ile Leu Phe 
Lys  Lys 
7  Gly Ala2 Ser Glue Lys  ?  Gly Alae Ser Glu2 Lys 
8  Val lle Glu Lys  104--107  Val Ile Glu Lys 
9  Not found  25-41?  Gly3 Ala Ser Leu2 Thr2 Glu4 
Pro2 Phe Lys 
10  Not found  ?  Gly2 Ser Leu Thr Glu2 Lys 
16  Set Leu Thr Lys  ?  Ser Leu Thr Lys 
19  Not found  97-103  Val Phe Gly3 Thr Lys 
24  Ser Leu Lys  ?  Ser Leu Lys 
29  Gly Pro Glu2 Lys  ?  Gly Pro Glu2 Lys 
30  Ala Pro Lys  43-45  Ala Pro Lys 
31  Val Thr Ile AECys~ Arg  19  24  Val Thr Ile Thr AECysJ; Arg 
33  Arg  108  Arg 
* The position in amino acid sequence is assigned on the basis of the homology with known 
sequences  of Bence  Jones proteins  (1). The composition  of peptides expressed  in integral 
molar residues  of amino  acids is indicated. Residues  italicized are those which  have been 
found to differ between the two proteins. 
;~ AECys indicates aminoethylcysteine. 
in one protein and not in the other. Moreover, not all the amino acid sequence of 
the variable half is accounted for by the peptides analyzed. This is easily ex- 
plained by the precipitation of some of the tryptic peptides at the end of the 
tryptic digestion (8). It is thus possible that more amino acid interchanges are 
present in these peptides. 
The  analysis of these two proteins shows that  the variability in amino acid 
sequence between  Bence Jones proteins of the same subtype is not limited to 
one or very few amino acid residues, but that, in general, many interchanges are 
present even in those proteins that give very similar peptide maps. 
Analysis of L  Type Bence Jones Proteins.--50 L  type proteins were analyzed 
bv  peptide mapping  (Table  III).  In  addition, 47  proteins were  analyzed by TABLE  III 
Type L Ben~e Jones proteins 
Protein  Oz  Fragment  Observations 
1  +  -- 
7  --  -- 
8  --  -- 
10  +  - 
12  -  - 
13  -  - 
17  -  - 
18  -  - 
20  +  - 
22  -  - 
25  +  -- 
27  --  + 
29  --  -- 
30  --  + 
32 
35  ?  -- 
37  --  -- 
38  -  + 
44  --  -- 
46  --  -- 
49  --  -- 
51  --  -- 
52  --  -- 
55  --  + 
57  --  - 
61  --  - 
69  +  - 
70  --  - 
74  -  -- 
76  --  - 
79  --  + 
87  --  - 
89  Not  examined  -- 
93  Not  examined  -- 
97  --  -- 
98  --  -- 
99  --  -- 
107  -  - 
108  -  - 
110  --  -- 
111  +  -- 
113  --  -- 
~i7  -  - 
125  --  -- 
129  Not  examined  - 
132  -  - 
133  -  - 
134  -  - 
135  -  - 
142  +  -- 
Subtype  I* 
Oz  peptide  not  found 
Subtype  I* 
Subtype  I* 
Serologically  Oz(+) 
*  Assignment  to  subtype  I  (25)  is based  on  analysis  of tryptic  peptides.  2 
409 410  r~UNOGLOBULIN  STRUCIuKE.  HI 
high voltage ionophoresis  to identify clearly the Oz peptide  (22).  7  of these 
proteins  showed  the  peptide  characteristic  of  Oz(+)  proteins,  whereas  39 
showed the peptide characteristic of Oz(--) proteins (23). The Oz peptide was 
not detected in one protein (BJ 35), which was not further investigated. The 
frequency of Oz(+) proteins determined on the sample of proteins analyzed 
was found to be 18 %. This frequency is considerably lower than that observed 
by Ein  and  Fahey  (24)  on a  smaller sample of Bence Jones  and  myeloma 
proteins. In order to compare our results with those of Ein and Fahey (24),  a 
sample of several of the proteins analyzed by us was sent to Dr. Daniel Ein for 
serological typing. For all proteins except one, the serological typing confirmed 
the chemical typing. The only exception was protein BJ 99, which typed sero- 
logically  as an Oz(+) protein, whereas by high  voltage ionophoresis  showed 
the Oz(--) peptide. 
Protein BJ 99 was further analyzed by Dr. Daniel Ein and by ourselves.  The 
Oz peptide was isolated by high voltage ionophoresis  and analyzed; it showed 
the amino acid composition characteristic of the Oz(--) peptide. It was thus 
concluded that  the  Oz  serological  test exceptionally does not type correctly 
Bence Jones proteins. It was thought possible that this may be caused by an 
extreme similarity of protein Oz and BJ 99 in the variable half. However, com- 
parison of peptide maps of these two proteins failed to reveal any striking simi- 
larity. No explanation could thus be provided for the abnormal typing of pro- 
tein BJ 99. 
The peptide maps of the proteins analyzed were found to differ in several 
peptides. In no instance did we observe two proteins very similar in their pep- 
tide maps, although some variable peptides were present in identical position 
in  several  proteins.  These  similarities  have  already  been  pointed  out  in  a 
previous publication. They are presumably related to the existence of four or 
five subtypes for L  type proteins (25, 26). It has, however, been impossible  so 
far to assign  L  type proteins to the proposed subtypes on the basis of  their 
peptide maps.  The only assignments have been made on the basis of  amino 
acid analysis of tryptic peptides (Table III). 
DISCUSSION 
Considerable variability has been observed in our sample of Bence Jones pro- 
teins analyzed by peptide mapping. In one case in which the peptide maps of 
two proteins looked almost identical, it was found by analyzing the tryptic pep- 
tides that these proteins differed in at least six positions.  This observation rules 
out genetic polymorphism as an important factor in the explanation of varia- 
bility of amino acid sequence of light chains of immunoglobulins.  It has been 
suggested that genetic polymorphism of human populations may in part account 
for variability  and  that  the  analysis of light  chains  produced by an  inbred 
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been found to correspond in all cases examined in detail to single amino acid 
interchanges in peptide chains synthesized under the control of allelic genes. 
The variability of immunoglobulin peptide chains can be explained by multi- 
ple genes in the germ line or by a somatic mechanism(s) which generates di- 
versity (1).  It seems relevant to evaluate thus the different sequences which 
may be presented in a species. This estimate can be obtained by a mathematical 
n--t000 
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Fzo. 2.  Probability curves of finding two identical Bence Jones proteins by analyzing a 
sample of k proteins out of a population of n  different proteins. The curves have been calcu- 
lated for different values of P, k, and n as described in the text. 
treatment of the  data obtained in  the present investigation similar to  that 
previously proposed (2-27). If one assumes that n light chain sequences exist in 
man (whether the corresponding genes are present in germ line or in somatic 
ceils is not relevant at this point), the probability P  of finding two identical 
light chains by examining a sample of k light chains is given by the following 
equation: 
p  _  n!/(n  --  k)! 
n k 
A series of probability curves calculated for different values of n and k are shown 
in Fig. 2. From these calculations, it seems clear that if the number of different 
light chain  sequences  were  of  the  order of a  few hundred, we should have 
found two identical light chains in our survey with a  good probability. Since 412  IMMUNOGLOBULIN  STRUCTURE.  HI 
we have failed to find two identical light chains, we can only set a lower esti- 
mate of the probable number n of different light chains that exist in man. We 
favor a rather large value of n, at least a few thousand. The estimate of n may 
eventually increase  when more sequences are analyzed or more proteins are 
compared by peptide mapping. 
The probable  existence of a rather large number of light chain sequences is 
an argument against germ line theories of genetic control of antibody structure. 
If the relationship,  one gene: one polypeptide chain, holds true for the immuno- 
globul{n.% several thousand genes may be necessary to code for all the immuno- 
globulin  chains.  The presence  of these genes with closely related nucleotide 
sequences and functions in the genome of vertebrates would pose several prob- 
lems. A sizeable part of the genome would be occupied by the immunoglobulin 
genes and rather complicated  control mechanisms  would be necessary  to in- 
duce two genes (one for the variable region of the light chain and one for the 
variable region on the heavy chain) of a very large population of similar genes. 
In addition, loss of genes similar  in nucleotide  sequence  may be caused by 
unequal crossing over (28), and this may result in marked instability of the 
immunoglobulin genes. 
The existence of subtypes of light chains (20, 25-26) is suggestive  on the 
other side of multiple genes for these proteins.  It seems quite evident that at 
least as many genes exist in the germ line as there are light chains subtypes. 
The differences in amino acid sequence between proteins of one subtype and 
those of a different subtype are so many, including differences in chain length, 
that they cannot be explained by any of the proposed mechanism(s)  by which 
somatic variability has been suggested to be generated (1). 
The relative frequency of proteins of different subtypes seems to be quite 
characteristic.  Among K type proteins,  those of subtype I  are by far the most 
frequent both in the proteins that we have analyzed and in those that have 
been sequenced  (1). Sequence studies of pooled serum immunoglobulin  light 
chains suggest  that K  type light chains of subtype I  are also predominant 
among the normal antibody population (29). The higher frequency of proteins 
of one subtype is somewhat difficult to reconcile with somatic theories of anti- 
body variability, unless one assumes that some basic sequences are used more 
frequently because  they function better in antibodies.  Alternatively, in germ 
line theories the relative frequency of proteins of different subtype can be cor- 
related with the presence in the genome of a widely different number of struc- 
tural genes for each subtype. A similar explanation may account for the dif- 
ferent proportion of heavy chain subclasses observed  in human pooled serum 
immunoglobulins  (2). 
The possibility that the subtypes of light chains contribute to the immuno- 
globulin population to a different degree in different species may be used to 
confute an argument which has been used against the germ line theories (29). R.  QUATTROCCHI,  D.  CIOLI,  AND  C.  BAGLIONI  413 
Characteristic  interspecies differences  in amino acid sequence have been ob- 
served when pooled serum fight chains have been examined; this has suggested 
that only a few structural genes for immunoglobulin chains exist in each species. 
It would seem impossible otherwise that all the immunoglobulin  genes would 
mutate accordingly to give sequences, characterized by the presence of seem- 
ingly invariable residues in some positions of the variable half of light chains 
(29). However, if one considers the possibility that in one species one subtype 
is predominant  (i.e., subtype KI in man) and that a different subtype is pre- 
dominant  in a  different species,  by sequencing pooled immunoglobulln%  one 
obtains the sequence of the subtype which is predominant in each species. It 
is then impossible to draw conclusions  on the origin  of the immunoglobufin 
genes,  since evolutionary divergence of the structural genes for the different 
subtypes might have preceded the extensive gene duplication postulated by 
the germ line theories. 
The data obtained in this investigation cannot be used to prove or disprove 
any of the current theories on the genetic control of antibody structure. They 
indicate  only that  the primary  structure  of immunoglobulin  fight  chains  is 
extremely variable and that possibly more subtypes of fight chains exist than 
have so far been recognized. 
SUMMARY 
102 human Bence Jones proteins have been purified by gel filtration, digested 
with trypsin, and analyzed by peptide mapping. In several cases Bence Jones 
"fragments", corresponding to the variable haft of the corresponding proteins, 
were observed. The peptide maps of the proteins were compared to establish 
whether any identical proteins were present in the sample analyzed. No Bence 
Jones protein showed a  peptide map identical  to that  of any other protein, 
although remarkable similarities  in the peptide maps were observed for some 
proteins. Two proteins that gave very similar peptide maps were then examined 
in detail, by purifying and analyzing the tryptic peptides. It was then found 
that these two proteins differ in amino acid sequence in at least six positions. 
The probability d  not finding two identical sequences by examining  a sample 
extracted from populations of fight chains of different sizes has been calculated. 
This has led to an estimate of the minimal  size of  the  population  of  light 
chain sequences in humans.  The number of light chain Sequences appears to 
be at least a few thousand. 
Information on the frequency of Inv and Oz antigenic determinants and on 
the relative frequency of subtypes of K chains has been obtained. Proteins of 
KI subtype are found most frequently. The possibility that different subtypes 
may be predominant in different species is discussed in relation to the evolu- 
tionary arguments used in favor of the somatic theories on the origin of vari- 
ability of immunoglobulin chains. 414  rM'MUNOGLOBITLIN  STRUCTURE. ILl 
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